Revelation Biosciences Investor Presentation Deck
October 2022, 18 slides
  1. Revelation Biosciences
  2. Related Decks
  3. Investor Presentation Decks
revelation developing innovative therapeutics to address unmet needs | Revelation Biosciences
forward looking statements | Revelation Biosciences
therapeutic development pipeline | Revelation Biosciences
is a well defined agonist with multiple potential applications sam infection via trained immunity augment the local and systemic adaptive immune response such as and nash treatment of food allergies and allergic rhinitis | Revelation Biosciences
revelation rev for the prevention of hospital associated | Revelation Biosciences
program highlights us licensed from additional related applications anticipated next step large market potential approximately of associated infection annual deaths | Revelation Biosciences
pretreatment with impart protection from gram negative bacterial infection treatment with or demonstrated mediated increased recruitment and reduced pro inflammatory a in peritoneal cavity treatment with and demonstrated mediated pathogen clearance | Revelation Biosciences
impart protection from gram positive bacterial infection treatment with and demonstrated improved pathogen clearance days post infection treatment with and demonstrated improved survival | Revelation Biosciences
revelation intramuscular vaccination | Revelation Biosciences
program highlights scientific rationale or transmission still active poor mucosal protection on robust mucosal protection vaccine adjuvant market growth nonclinical study in progress data | Revelation Biosciences
phase and phase clinical data supports mechanism of action phase data phase virus challenge data | Revelation Biosciences
revelation for the treatment of chronic kidney | Revelation Biosciences
program highlights myocarditis are propagated by inflammation followed by stimulation of via the pathway with way sue a ere | Revelation Biosciences
revelation | Revelation Biosciences
a rapid test kit for detection of intranasal is a diagnostic device in development for the detection of intranasal intranasal is an excellent for detecting an ear active respiratory infection influenza a and easy to use and understand kit that can be deployed anywhere inexpensive and easy to manufacture rapid results minutes kit design minimizes assignment of false negative | Revelation Biosciences
revelation financial overview | Revelation Biosciences
financial overview warrants all other management equity pool chairman fully diluted prime impact fund be | Revelation Biosciences
revelation for more information please visit thank you | Revelation Biosciences
See More
Revelation Biosciences
Investor Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Hospital
Related decks
Nuwellis
Investor Presentation
August 2023
MindMed
Investor Presentation
April 2021
DocGo
SPAC
May 2021
DocGo
Investor Presentation
November 2023
DocGo
Investor Day
June 2023
DocGo
Investor Presentation
May 2024
Genetron
IPO
July 2020
Teladoc
Investor Day
March 2020
Nuwellis
Investor Presentation
August 2023
MindMed
Investor Presentation
April 2021
DocGo
SPAC
May 2021
DocGo
Investor Presentation
November 2023
DocGo
Investor Day
June 2023
DocGo
Investor Presentation
May 2024
Genetron
IPO
July 2020
Teladoc
Investor Day
March 2020
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights